Global Human Insulin market accounted for USD 27.00 billion in 2015 and is expected to reach USD 43.6 billion by 2021, growing at a CAGR of around 8.3% between 2016 and 2021

1. Published By: Zion Market Research
Human Insulin Market by Product (Drug and Drug Delivery Devices) for Type 1
Diabetes, Type 2 Diabetes Application - Global Industry Perspective, Comprehensive
Analysis, Size, Share, Growth, Segment, Trends and Forecast, 2015 – 2021
Contact Us:
4283, Express Lane, Suite 634-143,
Sarasota, Florida 34249, United States
Tel: +1-386-310-3803 GMT
Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651
sales@zionmarketresearch.com

2. Human Insulin Market
Zion Research has published a new report titled “Human Insulin Market by Product (Drug and Drug
Delivery Devices) for Type 1 Diabetes, Type 2 Diabetes Application -Global Industry Perspective,
Comprehensive Analysis and Forecast, 2015 – 2021” According to the report, the global Human
Insulin market accounted for USD 27.00 billion in 2015 and is expected to reach USD 43.6 billion by
2021, growing at a CAGR of around 8.3% between 2016 and 2021.
The global human insulin market is expected to witness significant growth during the forecast period.
This growth is attributed due to increasing risk of diabetes, rising market demand for human insulin
analogs, technological advancements in the field of human insulin delivery devices, and favorable
medical reimbursements. An insulin regimen is often required in the treatment of gestational diabetes
and diabetes associated with certain conditions or syndromes (e.g.pancreatic diseases, drug- or
chemical-induced diabetes, endocrinopathies, insulin-receptor disorders, certain genetic syndromes).
In all instances of insulin use, the insulin dosage must be individualized and balanced with medical
nutrition therapy and exercise.
Browse the full "Human Insulin Market by Product (Drug and Drug Delivery Devices) for Type 1
Diabetes, Type 2 Diabetes Application - Global Industry Perspective, Comprehensive Analysis,
Size, Share, Growth, Segment, Trends and Forecast, 2015 – 2021" report
at https://www.zionmarketresearch.com/report/human-insulin-market

3. Human Insulin Market
Drugs segment dominated the human insulin market across globe in 2015 followed by drug delivery
device due to its excess demand, rising proportion of aging population in developed countries,
growing research & development for drug discovery & development, increasing market accessibility
of generic products worldwide, and rising government initiatives.

4. Human Insulin Market
In terms of drugs, biosimilars drugs were expected to account for the largest market share of the
human insulin market in upcoming forecast period. Demand for biosimilar drugs is strong in both
developed and developing countries due to its low cost therapy. This is driven by the need for the best
valuable treatment, which can often be expensive. Biosimilar insulin drug may offer a less-costly
alternative to existing human insulin biologics.
Request for sample report @ https://www.zionmarketresearch.com/sample/human-insulin-
market
On the basis of drug delivery device, the pens segment is expected to account for the largest market
share in 2015 followed by syringe and pen Needle. This growth can be endorsed due to growing
market focus of pen manufacturers on emerging countries such as China, India and Brazil. Insulin
pens look similar to oversized ink pens, making them a potentially convenient and discreet way of
carrying insulin which makes him one of the demanding factors over the other market.
Key market players of human insulin market include Eli Lilly, GlaxoSmithCline, Biocon, Sanofi
Aventis, Julphar, Novo Nordisk, SemBioSys, Ypsomed AG and Wockhardt.
This report segments the global human insulin market as follows:
Human Insulin Market: Product Segment Analysis
 Drugs
o Insulin Analogs and Biosimilars

5. Human Insulin Market
o Human Insulin Biologics
 Drug Delivery Devices
o Pens
o Pen Needles
o Syringes
Human Insulin Market: Application Segment Analysis
 Insulin dependent diabetes mellitus (Type 1)
 Non-Insulin dependent diabetes mellitus (Type 2)
Human Insulin Market: Regional Segment Analysis
 North America
 Europe
 Asia Pacific
 Latin America
 Middle East & Africa
Request for sample report @ https://www.zionmarketresearch.com/sample/human-insulin-
market

6. Human Insulin Market
Browse the full "Human Insulin Market by Product (Drug and Drug Delivery Devices) for Type 1
Diabetes, Type 2 Diabetes Application - Global Industry Perspective, Comprehensive Analysis,
Size, Share, Growth, Segment, Trends and Forecast, 2015 – 2021" report
at https://www.zionmarketresearch.com/report/human-insulin-market
Zion Market Research
Address: 4283, Express Lane, Suite 634-143, Sarasota, Florida 34249, United States
Tel: +1-386-310-3803 GMT
+49-322 210 92714 Tel: +1-855-465-4651 (US/CAN TOLL FREE)
Email: sales@zionmarketresearch.comWeb:www.zionmarketresearch.com